Miller K, Kieselbach G F, Niederwieser D, Huber C, Margreiter R, Göttinger W
Klin Monbl Augenheilkd. 1985 Nov;187(5):394-7. doi: 10.1055/s-2008-1054345.
It is generally accepted that corneal grafts in hypervascular and sclerosed host corneas have little chance of success. At the end of a three-month postoperative immunosuppression period using the new immunosuppressant Cyclosporin A, full incorporation of transplants was achieved in 10 out of 11 high-risk patients. Patients were observed over a period of between 3 and 15 months, the median being 9 months.
一般认为，在血管增生和硬化的宿主角膜中进行角膜移植成功的机会很小。在使用新型免疫抑制剂环孢素A进行为期三个月的术后免疫抑制期结束时，11例高危患者中有10例实现了移植片的完全融合。对患者进行了3至15个月的观察，中位数为9个月。
